Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

NEOGENOMICS, INC.

(NEO)
  Report
Real-time Estimate Quote. Real-time Estimate Cboe BZX - 12/03 10:28:54 am
30.945 USD   -4.31%
11/30NEOGENOMICS : To Participate In The Stephens Annual Investment Conference 2021
PU
11/29INSIDER SELL : Neogenomics
MT
11/10NEOGENOMICS INC : Change in Directors or Principal Officers (form 8-K)
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

NeoGenomics, Inc. Announces Board Changes

10/12/2021 | 05:03pm EST

NeoGenomics, Inc. announced that on October 5, 2021, Douglas M. VanOort, the former Chief Executive Officer of NeoGenomics, Inc. and currently the Company's Executive Chairman and Chairman of the Board of Directors of the ompany, notified the Board of his voluntary decision to retire from the company and that in connection with his retirement he was tendering his resignation as Executive Chairman and Chairman of the Board of the company, effective October 7, 2021. Mr. VanOort will remain as a director on the Board but plans to retire as a member of the Board before the end of the year as the Board concludes an ongoing search process. Mr. VanOort's decision to retire and resign as Executive Chairman and Chairman of the Board was not the result of any dispute or disagreement with the company, the Company's management or the Board on any matter relating to the operations, policies or practices of the company. The company announced a transition in the leadership of its Board of Directors. Ms. Lynn A. Tetrault, former Lead Independent Director, has been appointed Non-executive Chair of the Board of Directors. Ms. Tetrault replaces Douglas M. VanOort who served as Chairman and CEO from 2009 through April 2021 and recently as Executive Chair of the NeoGenomics Board of Directors. As part of the transition, Mr. VanOort will be stepping down as Executive Chairman and plans to retire as a member of the Board of Directors before the end of the year as the Board concludes an ongoing search process.


ę S&P Capital IQ 2021
All news about NEOGENOMICS, INC.
11/30NEOGENOMICS : To Participate In The Stephens Annual Investment Conference 2021
PU
11/29INSIDER SELL : Neogenomics
MT
11/10NEOGENOMICS INC : Change in Directors or Principal Officers (form 8-K)
AQ
11/10NeoGenomics, Inc. Appoints William Bonello as Chief Financial Officer, Effective Januar..
CI
11/10NeoGenomics, Inc. Appoints Kathryn Mckenzie as Chief Sustainability and Risk Officer, E..
CI
11/10NeoGenomics, Inc. Appoints Dave Daly to Its Board of Directors
CI
11/10NeoGenomics Appoints Dave Daly to Its Board of Directors
PU
11/08Morgan Stanley Cuts NeoGenomics to Equal-Weight From Overweight, Price Target to $45 Fr..
MT
11/08Genetron Holdings, NeoGenomics to Collaborate to Provide China-Based Medical Research S..
MT
11/08Genetron Health Establishes Strategic Partnership with NeoGenomics to Drive Global Onco..
AQ
More news
Analyst Recommendations on NEOGENOMICS, INC.
More recommendations
Financials (USD)
Sales 2021 485 M - -
Net income 2021 0,67 M - -
Net Debt 2021 288 M - -
P/E ratio 2021 -9 712x
Yield 2021 -
Capitalization 3 982 M 3 982 M -
EV / Sales 2021 8,81x
EV / Sales 2022 7,61x
Nbr of Employees 1 700
Free-Float 96,0%
Chart NEOGENOMICS, INC.
Duration : Period :
NeoGenomics, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends NEOGENOMICS, INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 11
Last Close Price 32,34 $
Average target price 51,70 $
Spread / Average Target 59,9%
EPS Revisions
Managers and Directors
Mark Mallon Chief Executive Officer & Director
George A. Cardoza President & Chief Operating Officer-Lab Operations
Kathryn B. McKenzie Chief Financial Officer
Lynn A. Tetrault Non-Executive Chairman
Steven A. Ross Chief Information Officer & Vice President
Sector and Competitors